For over twenty years, we have been a trusted leader among imaging CROs. We provide a wide range of blinded clinical trial data assessment and management services, which include assessments of non-imaging subjective data, such as patient outcomes and adverse reactions.
Using rigorous independent review (IR) training and testing paradigms, we minimize and monitor variability of IR data with a cost-efficient adaptive design approach. By taking into account the endpoint measured, type of adjudication and number of adjudication triggers, WCC enhances the precision and accuracy of your blinded independent central review (BICR) data.
Imaging services are the core of our business:
Independent Endpoint Assessment Committees (EACs) are increasingly being requested by regulatory agencies to decrease bias in interpretation of subjective endpoints. WCC has pioneered the structures of the digital endpoint adjudication process and has recently and successfully completed one of the first endpoint committee audits by the FDA. WCC’s EAC services include expert assessments by physicians drawn from multiple therapeutic areas for comprehensive efficacy and safety reviews.Learn More
For sponsors conducting early-stage and Phase II trials, WCC offers the Collect-Ready-Hold service for streamlined review. This provides images that are QC'd and ready for third party review.Learn More
With the growing importance of safety reviews in clinical trials, there is a need for quick turnaround for safety assessments. WCC offers 24-hour turnaround services on all types of clinical imaging reviews seven days a week.Learn More